查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
乾癬性關節炎的全球市場 - 市場佔有率，規模，趨勢，產業分析:各給藥途徑，各類藥物，各流通管道，各地區，市場區隔預測(2022年～2030年)
市場調查報告書
商品編碼
1150066

乾癬性關節炎的全球市場 - 市場佔有率，規模，趨勢，產業分析:各給藥途徑，各類藥物，各流通管道，各地區，市場區隔預測(2022年～2030年)

Psoriatic Arthritis Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral, Topical); By Drugs Class; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

全球乾癬性關節炎的市場規模在2030年前將達到222億美元。

本報告提供全球乾癬性關節炎市場相關調查，提供市場動態，各市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查目的
    • 市場範圍
    • 前提條件
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資訊來源
    • 一次資訊
    • 二次資訊

第4章 全球乾癬性關節炎市場洞察

  • 乾癬性關節炎 - 產業的概述
  • 乾癬性關節炎市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力
    • 新加入廠商者的威脅
    • 買方議價能力
    • 替代品的威脅
    • 現有企業間的競爭力
  • PESTEL分析
  • 乾癬性關節炎市場產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球乾癬性關節炎市場:各類藥物

  • 主要調查結果
  • 簡介
    • 全球乾癬性關節炎市場:各類藥物(2018年～2030年)
  • 非類固醇消炎劑(NSAIDs)
    • 全球乾癬性關節炎市場:非類固醇消炎劑(NSAIDs)，各地區(2018年～2030年)
  • 非生物學的緩解疾病性抗風濕藥(DMARD)
    • 全球乾癬性關節炎市場:非生物學的緩解疾病性抗風濕藥(DMARD)，各地區(2018年～2030年)
  • 生物學的緩解疾病性抗風濕藥(DMARD)
    • 全球乾癬性關節炎市場:生物學的緩解疾病性抗風濕藥(DMARD)，各地區(2018年～2030年)
  • 其他
    • 全球及其他的乾癬性關節炎市場:各地區(2018年～2030年)

第6章 全球乾癬性關節炎市場:各給藥途徑

  • 主要調查結果
  • 簡介
    • 全球乾癬性關節炎市場:各給藥途徑(2018年～2030年)
  • 口服
    • 全球乾癬性關節炎市場:口服，各地區(2018年～2030年)
  • 非口服
    • 全球乾癬性關節炎市場:非口服，各地區(2018年～2030年)
  • 局部
    • 全球乾癬性關節炎市場:局部，各地區(2018年～2030年)

第7章 全球乾癬性關節炎市場:各流通管道

  • 主要調查結果
  • 簡介
    • 全球乾癬性關節炎市場:各流通管道(2018年～2030年)
  • 醫院藥局
    • 全球乾癬性關節炎市場:醫院藥局，各地區(2018年～2030年)
  • 零售藥局
    • 全球乾癬性關節炎市場:零售藥局，各地區(2018年～2030年)
  • 線上藥局
    • 全球乾癬性關節炎市場:線上藥局，各地區(2018年～2030年)

第8章 全球乾癬性關節炎市場:各地區

  • 主要調查結果
  • 簡介
    • 乾癬性關節炎市場評估:各地區(2018年～2030年)
  • 北美
    • 各類藥物(2018年～2030年)
    • 各流通管道(2018年～2030年)
    • 各給藥途徑(2018年～2030年)
    • 美國
    • 加拿大
  • 歐洲
    • 各類藥物(2018年～2030年)
    • 各流通管道(2018年～2030年)
    • 各給藥途徑(2018年～2030年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 各類藥物(2018年～2030年)
    • 各流通管道(2018年～2030年)
    • 各給藥途徑(2018年～2030年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲
    • 各類藥物(2018年～2030年)
    • 各流通管道(2018年～2030年)
    • 各給藥途徑(2018年～2030年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 各類藥物(2018年～2030年)
    • 各流通管道(2018年～2030年)
    • 各給藥途徑(2018年～2030年)
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭情形

  • 事業擴大和收購的分析
    • 事業擴大
    • 收購
  • 夥伴關係/合作/協定/展示會

第10章 企業簡介

  • AbbVie Inc
  • AstraZeneca PLC
  • Amgen Inc
  • Bausch Health Companies Inc
  • Bristol-Myers Squibb Company
  • Celgene Corp
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc
  • Novartis International AG
  • Pfizer, Inc.
  • UCB S.A
Product Code: PM1346

The global psoriatic arthritis market size is expected to reach USD 22.20 billion by 2030, according to a new study by Polaris Market Research. The report "Psoriatic Arthritis Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral, Topical); By Drugs Class; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Some of the main drivers of the market growth include hectic lifestyles that exceed the maximum immune system, a rapidly aging population, growth in psoriasis incidence, increasing incomes that make enormous biologic treatment options more inexpensive, and a rise in the incidence of product portfolio approvals.

For instance, In March 2019, AbbVie Inc. announced that the interleukin-23 (IL-23) receptor SKYRIZI (risankizumab) has already been authorized by the Japanese Department of Health, Labour, and Welfare (MHLW) for adult patients being treated with psoriatic arthritis, generalized suppurative psoriasis, erythema psoriasis, and rheumatic diseases who haven't responded well.

The need for PsA medications for treatment is expected to rise due to the rising prevalence of psoriatic arthritis, an autoimmune illness brought on by the body's immune system attacking the skin and joints. People who already have plaque psoriasis are more likely to develop the condition. About 30% of people with psoriasis go on to develop PsA, an inflammatory disorder that affects the joints, according to a study released by Celgene Corporation.

The expansion of the market is anticipated to be fueled by the rising number of medication approvals from regulatory agencies. For instance, In December 2019, Pfizer Inc. declared that the USFDA had authorized its Infliximab product type, a monoclonal antibody (mAb) against tumor necrosis factor, as a product to Remicade for the treatment of individuals with rheumatoid arthritis, ulcerative colitis, Crohn's disease, ankylosing psoriatic arthritis, psoriatic arthritis, and plaque.

Psoriatic Arthritis Market Report Highlights

The online pharmacies segment is anticipated to grow at a significant CAGR over the forecast period due to increased internet use around the world, the comfort of online shopping, and the numerous discounts that are available through pharmacy sites.

The non-steroidal anti-inflammatory medicine segment is anticipated to dominate the market for treating PsA soon by earning the maximum share owing to the demand for immunosuppressive medications, robust sales of currently available goods, and growth in the number of launches of attractive pipeline candidates.

Asia Pacific is anticipated to grow with the fastest CAGR over the forecast period. One of the critical aspects expected to stimulate the development of biological therapies for psoriasis in China is the increasing incidence of obesity. Smoking, excessive alcohol consumption, and the development of unhealthy lifestyles are expected to drive the market in this country.

The global players include AbbVie, Amgen, AstraZeneca, Bausch Health, and Bristol-Myers Squibb.

Polaris Market Research has segmented the psoriatic arthritis market report based on drug class, route of administration, distribution channel, and region:

Psoriatic Arthritis, Drug Class Outlook (Revenue - USD Billion, 2018 - 2030)

Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

Others

Psoriatic Arthritis, Route Of Administration Outlook (Revenue - USD Billion, 2018 - 2030)

Oral

Parenteral

Topical

Psoriatic Arthritis, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Psoriatic Arthritis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Psoriatic Arthritis Market Insights

  • 4.1. Psoriatic Arthritis - Industry Snapshot
  • 4.2. Psoriatic Arthritis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in prevalence of psoriatic arthritis to fuel market growth
      • 4.2.1.2. Presence of a strong pipeline of drug to spur market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Psoriatic Arthritis Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Psoriatic Arthritis Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • 5.3. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 5.3.1. Global Psoriatic Arthritis Market, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), by Region, 2018 - 2030 (USD Billion)
  • 5.4. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
    • 5.4.1. Global Psoriatic Arthritis Market, by Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), by Region, 2018 - 2030 (USD Billion)
  • 5.5. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
    • 5.5.1. Global Psoriatic Arthritis Market, by Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), by Region, 2018 - 2030 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Other Psoriatic Arthritis Market, by Region, 2018 - 2030 (USD Billion)

6. Global Psoriatic Arthritis Market, by Route Of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Psoriatic Arthritis Market, by Oral, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Psoriatic Arthritis Market, by Parenteral, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Topical
    • 6.5.1. Global Psoriatic Arthritis Market, by Topical, by Region, 2018 - 2030 (USD Billion)

7. Global Psoriatic Arthritis Market, by Distribuation Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Psoriatic Arthritis Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Psoriatic Arthritis Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Psoriatic Arthritis Market, by Online Pharmacies, by Region, 2018 - 2030 (USD Billion)

8. Global Psoriatic Arthritis Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Psoriatic Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Psoriatic Arthritis Market - North America
    • 8.3.1. North America: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.3.4. Psoriatic Arthritis Market - U.S.
      • 8.3.4.1. U.S.: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.3.5. Psoriatic Arthritis Market - Canada
      • 8.3.5.1. Canada: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • 8.4. Psoriatic Arthritis Market - Europe
    • 8.4.1. Europe: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.4. Psoriatic Arthritis Market - UK
      • 8.4.4.1. UK: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.5. Psoriatic Arthritis Market - France
      • 8.4.5.1. France: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.6. Psoriatic Arthritis Market - Germany
      • 8.4.6.1. Germany: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.7. Psoriatic Arthritis Market - Italy
      • 8.4.7.1. Italy: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.8. Psoriatic Arthritis Market - Spain
      • 8.4.8.1. Spain: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.9. Psoriatic Arthritis Market - Netherlands
      • 8.4.9.1. Netherlands: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.4.10. Psoriatic Arthritis Market - Russia
      • 8.4.10.1. Russia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • 8.5. Psoriatic Arthritis Market - Asia Pacific
    • 8.5.1. Asia Pacific: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.4. Psoriatic Arthritis Market - China
      • 8.5.4.1. China: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.5. Psoriatic Arthritis Market - India
      • 8.5.5.1. India: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.6. Psoriatic Arthritis Market - Malaysia
      • 8.5.6.1. Malaysia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.7. Psoriatic Arthritis Market - Japan
      • 8.5.7.1. Japan: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.8. Psoriatic Arthritis Market - Indonesia
      • 8.5.8.1. Indonesia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.5.9. Psoriatic Arthritis Market - South Korea
      • 8.5.9.1. South Korea: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • 8.6. Psoriatic Arthritis Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.6.4. Psoriatic Arthritis Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.6.5. Psoriatic Arthritis Market - UAE
      • 8.6.5.1. UAE: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.6.6. Psoriatic Arthritis Market - Israel
      • 8.6.6.1. Israel: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.6.7. Psoriatic Arthritis Market - South Africa
      • 8.6.7.1. South Africa: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • 8.7. Psoriatic Arthritis Market - Latin America
    • 8.7.1. Latin America: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.7.4. Psoriatic Arthritis Market - Mexico
      • 8.7.4.1. Mexico: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.7.5. Psoriatic Arthritis Market - Brazil
      • 8.7.5.1. Brazil: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
    • 8.7.6. Psoriatic Arthritis Market - Argentina
      • 8.7.6.1. Argentina: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca PLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amgen Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bausch Health Companies Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bristol-Myers Squibb Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Celgene Corp
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Eli Lilly and Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson Services, Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novartis International AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. UCB S.A
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 2 Global Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 3 Global Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 4 Psoriatic Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 6 North America: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 7 North America: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 17 UK: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 18 UK: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 19 UK: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 20 France: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 21 France: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 22 France: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 35 Russia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 36 Russia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 37 Russia: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 41 China: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 42 China: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 43 China: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 44 India: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 45 India: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 46 India: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Psoriatic Arthritis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Psoriatic Arthritis Market, by Route Of Administration, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Psoriatic Arthritis Market, by Distribuation Channel, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Psoriatic Arthritis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Route Of Administration

Figure 7. Global Psoriatic Arthritis Market, by Route Of Administration, 2021 & 2030 (USD Billion)

Figure 8. Market by Drug Class

Figure 9. Global Psoriatic Arthritis Market, by Drug Class, 2021 & 2030 (USD Billion)

Figure 10. Market by Distribuation Channel

Figure 11. Global Psoriatic Arthritis Market, by Distribuation Channel, 2021 & 2030 (USD Billion)

Figure 12. Psoriatic Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 13. Strategic Analysis - Psoriatic Arthritis Market